Active Surveillance for Low-Risk Prostate Cancer Reply

被引：0
作者：
Lellig, Katja [1 ]
Buchner, Alexander [1 ]
Stief, Christian [1 ]
机构：
[1] Univ Munich, Klinikum Grosshadern, Urol Klin & Poliklin, D-80539 Munich, Germany
来源：
UROLOGE | 2015年 / 54卷 / 06期
关键词：
RADICAL PROSTATECTOMY;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：870 / 870
页数：1
相关论文
共 50 条
  • [41] The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial
    Schiavina, Riccardo
    Droghetti, Matteo
    Novara, Giacomo
    Bianchi, Lorenzo
    Gaudiano, Caterina
    Panebianco, Valeria
    Borghesi, Marco
    Piazza, Pietro
    Bianchi, Federico Mineo
    Guerra, Marco
    Corcioni, Beniamino
    Fiorentino, Michelangelo
    Giunchi, Francesca
    Verze, Paolo
    Pultrone, Cristian
    Golfieri, Rita
    Porreca, Angelo
    Mirone, Vincenzo
    Brunocilla, Eugenio
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (07) : 433.e1 - 433.e7
  • [42] Should men with low-risk, localized prostate cancer choose active surveillance or undergo a robotic prostatectomy?
    Peter Albertsen
    Current Urology Reports, 2008, 9 (1) : 1 - 2
  • [43] Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer
    Suardi, Nazareno
    Briganti, Alberto
    Gallina, Andrea
    Salonia, Andrea
    Karakiewicz, Pierre I.
    Capitanio, Umberto
    Freschi, Massimo
    Cestari, Andrea
    Guazzoni, Giorgio
    Rigatti, Patrizio
    Montorsi, Francesco
    BJU INTERNATIONAL, 2010, 105 (11) : 1548 - 1552
  • [44] Prostate volume is an independent predictive factor in selecting low-risk prostate patients for active surveillance
    Yusim, Igor
    Mazor, Elad
    Elsaraya, Nimer
    Gat, Roni
    Novack, Victor
    Mabjeesh, Nicola J.
    FRONTIERS IN UROLOGY, 2022, 2
  • [45] The Risk of Upstaged Disease Increases with Body Mass Index in Low-Risk Prostate Cancer Patients Eligible for Active Surveillance
    Ploussard, Guillaume
    de la Taille, Alexandre
    Bayoud, Younes
    Durand, Xavier
    Terry, Stephane
    Xylinas, Evanguelos
    Allory, Yves
    Vacherot, Francis
    Abbou, Claude-Clement
    Salomon, Laurent
    EUROPEAN UROLOGY, 2012, 61 (02) : 356 - 362
  • [46] Active Surveillance of Low- Risk- Prostate Cancer
    Weissbach, L.
    UROLOGE, 2015, 54 (06): : 869 - 869
  • [47] Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients
    Suardi, Nazareno
    Gallina, Andrea
    Capitanio, Umberto
    Salonia, Andrea
    Lughezzani, Giovanni
    Freschi, Massimo
    Mottrie, Alexander
    Rigatti, Patrizio
    Montorsi, Francesco
    Briganti, Alberto
    CANCER, 2012, 118 (04) : 973 - 980
  • [48] Is Advocacy for Active Surveillance Over Definitive Intervention in Low-Risk Prostate Cancer Applicable to African American Patients?
    McClelland, Shearwood, III
    Jaboin, Jerry J.
    Mitin, Timur
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (05): : 1076 - 1077
  • [49] Evaluation of Diffusion-Weighted MR Imaging at Inclusion in an Active Surveillance Protocol for Low-Risk Prostate Cancer
    Somford, Diederik M.
    Hoeks, Caroline M.
    Hulsbergen-van de Kaa, Christina A.
    Hambrock, Thomas
    Futterer, Jurgen J.
    Witjes, J. Alfred
    Bangma, Chris H.
    Vergunst, Henk
    Smits, Geert A.
    Oddens, Jorg R.
    van Oort, Inge M.
    Barentsz, Jelle O.
    INVESTIGATIVE RADIOLOGY, 2013, 48 (03) : 152 - 157
  • [50] Results of active surveillance in low and intermediate risk prostate cancer
    Llorente, Carlos
    Diaz Goizueta, Francisco Javier
    Hernandez, Virginia
    Manuel de la Morena, Jose
    de la Pena, Enrique
    ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (05): : 452 - 456
12345